AbbVie looks to sell $5 billion portfolio

by on

The drugmaker is in talks to divest its women’s health unit, which it picked up last year through its $63 billion Allergan acquisition.

The drugmaker is in talks to divest its women’s health unit, which it picked up last year through its $63 billion Allergan acquisition.

VA:F [1.9.7_1111]
Rating: 0.0/10 (0 votes cast)
VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)

Leave a Comment

Previous post:

Next post: